Zydus Wellness Limited

Fast Moving Consumer Goods · Food Products

NSE: ZYDUSWELL BSE: 531335
₹512.80
▲ 6.70 (1.32%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
50/100
Moderate
Valuation
32/100
Fairly Valued
Momentum
31/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

About

Zydus Wellness is an Indian consumer goods company, which produces nutrition and skincare products. Headquartered in Ahmedabad, it is a subsidiary of the pharmaceutical company Zydus Lifesciences. Its brands include Glucon-D, Sugar Free, EverYuth, Complan, and Nycil. As of 2021, the company operates three manufacturing plants, one in Gujarat and two in Sikkim.

Source: Wikipedia

Key Metrics

Market Capitalization
₹16,315 Cr
PE (TTM)
423.8
Industry median 30.0 (70 companies)
Price to Book
2.8
PEG (TTM)
-5.6
Institutions holding %
22.46%
FII + DII, latest filed period
Piotroski Score
6
Relative return vs Nifty50, qtr %
-6.6
Relative return vs Sector, qtr %
1.9
Free Cash Flow
₹125 Cr
as of March 31, 2026
Industry median ₹-1 Cr (116 companies)
EPS Growth (YoY)
-84.55%
as of June 30, 2026
Industry median 1.00% (86 companies)
Net Profit Growth (TTM)
22.61%
as of June 30, 2026
Industry median 13.98% (86 companies)
Operating Revenue Growth (TTM)
87.50%
as of June 30, 2026
Industry median 10.71% (86 companies)
Profit Growth (YoY)
-21.43%
as of June 30, 2026
Industry median 12.63% (87 companies)
Revenue Growth (YoY)
74.46%
as of June 30, 2026
Industry median 9.85% (80 companies)
Current Ratio
1.88
as of March 31, 2026
Industry median 2.22 (115 companies)
Debt to Equity
0.55
as of March 31, 2026
Industry median 0.24 (95 companies)
Interest Coverage
5.13
as of June 30, 2026
Industry median 4.86 (88 companies)
Net Margin
3.59%
as of June 30, 2026
Industry median 3.59% (83 companies)
Operating Margin (EBIT)
6.80%
as of June 30, 2026
Industry median 6.55% (85 companies)
Operating Margin (TTM)
10.10%
as of June 30, 2026
Industry median 6.00% (90 companies)
Return on Assets
1.91%
as of March 31, 2026
Industry median 3.76% (89 companies)
Return on Capital Employed
3.43%
as of March 31, 2026
Industry median 13.81% (88 companies)
Return on Equity
3.38%
as of March 31, 2026
Industry median 7.67% (89 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 8 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • Yes Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Piotroski F-score is 7 or more (score 6)
  • No Debt to equity is below 0.5 (0.55)
  • No Return on equity is 15% or more (3.4%)
  • Yes Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

4 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

0 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
1.3%
Low 500.2000 · High 518.6000
1W return
-3.4%
Low 500.2000 · High 529.4500
1M return
-3.3%
Low 500.2000 · High 581.0000
52W return
11.5%
Low 367.5500 · High 611.8500
Lifetime High ₹2621.3000 (Sept. 16, 2025)
Lifetime Low ₹196.6000 (Nov. 16, 2009)

Full price history and technicals →

EMA & SMA

Bullish1
Bearish5
5D
516.8
10D
523.1
20D
528.6
50D
532.2
100D
521.8
200D
486.2

Delivery and volume

Day avg. delivery
49.9%
Week avg. delivery
46.6%
Month avg. delivery
21.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

510.53
Pivot
First resistance520.87
Second resistance528.93
Third resistance539.27
First support502.47
Second support492.13
Third support484.07
Day RSI42.4
Day MFI20.9
Day MACD-5.32
Day MACD signal-1.79

Beta

1M0.18
3M0.73
1Y0.54
3Y0.47

Price change analysis

↓ -3.3%
Over 1 Month
LowHigh
500.20581.00
↓ -9.8%
Over 3 Months
LowHigh
490.00611.85
↑ 17.7%
Over 6 Months
LowHigh
420.30611.85
↑ 11.5%
Over 1 Year
LowHigh
367.55611.85
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 423.8 (own history: 116.6–475.5)
Sell Zone
Revenue (June 30, 2026)
₹153 Cr
Net profit (June 30, 2026)
₹6 Cr
Basic EPS (June 30, 2026)
₹0.1700

Ranks #4 of 96 in Food Products by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter69.64%
  • Mutual funds18.73%
  • FII/FPI3.32%
  • Other DII0.41%
  • Public7.90%

Largest holders

NameCategoryShares %Shares
Zydus Lifesciences LimitedPromoter57.5900%183237545
Zydus Family Trust(Trustee:Mr. Pankaj R. Patel,Smt. Pritiben P. Patel, Dr. Sharvil P. Patel)Promoter12.0100%38225795
Parag Parikh Flexi Cap FundPublic7.3300%23320774
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap FundPublic5.9100%18800480
Quant Mutual Fund - Quant Small Cap FundPublic4.2300%13452203

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 69.63% to 69.64% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings increased from 3.18% to 3.32% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 18.43% to 18.73% in Jun 2026 qtr

10 mutual fund schemes also hold this stock.

All shareholding details →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
18 Mar 2026 Rinesh Gajjar Employee / designated person Buy 0 ₹0
9 Mar 2026 Rajat Bhargava Employee / designated person Buy 0 ₹0
9 Mar 2026 Vineet Shrivastava Employee / designated person Buy 0 ₹0
9 Mar 2026 Yatin Desai Employee / designated person Buy 0 ₹0
6 Mar 2026 Punit Adhia Employee / designated person Buy 0 ₹0
3 Mar 2026 Umesh Vinodray Parikh Key managerial personnel Buy 0 ₹0
2 Mar 2026 Vineet Shrivastava Employee / designated person Buy 0 ₹0
17 Feb 2026 Umesh Vinodray Parikh Employee / designated person Buy 0 ₹0
16 Feb 2026 Tarun G Arora Employee / designated person Buy 0 ₹0
10 Feb 2026 Nidhi Punit Adhia Employee / designated person Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
13 Mar 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 3,136,345 428.5300 NSE
13 Mar 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 3,136,345 428.8200 NSE
13 Mar 2026 IRAGE BROKING SERVICES LLP Bulk Buy 1,701,292 428.7500 NSE
13 Mar 2026 IRAGE BROKING SERVICES LLP Bulk Sell 1,664,411 425.3900 NSE
17 Jun 2025 THREPSI CARE LLP Block Sell 4,627,111 1900.0000 NSE
17 Jun 2025 PPFAS MUTUAL FUND Block Buy 4,627,111 1900.0000 NSE
6 Aug 2024 THREPSI CARE LLP Block Sell 1,700,000 2201.4000 NSE
6 Aug 2024 QUANT MUTUAL FUND Block Buy 1,700,000 2201.4000 NSE
28 Dec 2023 ZYDUS FAMILY TRUST Block Buy 390,000 1632.0000 NSE
28 Dec 2023 THREPSI CARE LLP Block Sell 780,000 1632.0000 NSE

All bulk and block deals →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Carnation Nutra-Analogue Foods Limited to Zydus Wellness Limited

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
4 Aug 2026 Financial Results Yes
18 May 2026 Financial Results/Dividend Yes
3 Feb 2026 Financial Results Yes
5 Nov 2025 Financial Results Yes
30 Jul 2025 Financial Results Yes

Corporate Announcements

All 4 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Company Update Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication
18 Sep 2026 Company Update Zydus Wellness Ltd-$ - 531335 - Announcement under Regulation 30 (LODR)-Change in Management
8 Sep 2026 Company Update Zydus Wellness Ltd-$ - 531335 - Clarification On Volume Movement
8 Sep 2026 Company Update Zydus Wellness Ltd-$ - 531335 - Clarification sought from Zydus Wellness Ltd

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.88)
  • Strong revenue growth YoY (74.5%)

Weaknesses

  • Low Return on Equity (3.4%)
  • Thin net profit margin (3.6%)
  • Declining profit YoY (-21.4%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (423.8) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500, NIFTY 500

Frequently asked questions about Zydus Wellness Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.